Venture Capital

Behind EVs, AI, and medical breakthroughs lies a hidden process. Discover how ion implantation shapes the chips that power our future and our trust in it.

A new partnership signals a shift towards versatile, American-made drone systems, streamlining critical missions and challenging market incumbents.

Early Phase 1 data for VTP-1000 shows promise, but can this novel immunotherapy challenge a crowded market and change life for 80 million patients?

As drone attacks paralyze European airports, an Israeli tech firm's 'soft kill' net system emerges as a key contender for NATO's defense strategy.

Chemical giant Nouryon is doubling down on Brazil, building a new innovation hub to co-create sustainable beauty and cleaning products for a booming market.

Professor Youmin Xi's recent honor signals more than academic success. It marks a strategic blueprint for cultivating the next generation of life science leaders.

Behind the rise of regional streaming giant Chaupal lies a massive tech overhaul. Discover how a B2B partnership enabled a seamless 10M user migration.

A novel drug for heart failure shows promising safety and efficacy data, potentially disrupting a multi-billion dollar market and validating a key investor's strategy.

Bill Ackman's fund is buying back its own shares at a deep discount. We explore the innovative financial strategy and its impact on shareholder value.

Hexagon Purus erases a $12.9M debt in its Panasonic battery deal but gives up lucrative US tax credits, a move securing its supply chain at a high cost.

Following stellar clinical data, Terns Pharmaceuticals' upsized $650M offering signals massive investor confidence and funds its push to disrupt the CML market.

Gossamer Bio's recent 200,000-share grant to a new hire is more than a welcome bonus; it's a strategic bet on its blockbuster drug candidate.

Coveo manages a key executive transition by doubling down on its AI-driven growth story, reassuring investors that its innovation engine remains in high gear.

With a new $730K grant, Sunrise New Energy is tackling silicon-carbon anode challenges to unlock the next generation of high-density batteries.

A prestigious Yale recognition for board member Dr. Curtis Patton bolsters Tevogen's credibility as it advances its AI and T-cell platforms.

A new software-defined radio isn't just a product launch; it's a strategic masterstroke, embracing open standards to reshape electronic warfare and investment.

A California fragrance brand conquered Korea and now targets the U.S. We dissect the data-driven strategy and AI's quiet role in its rapid rise.

A landmark deal between Airspan and Rakuten, backed by US funds, marks a new era for open networks, challenging the global telecom supply chain.

A regulatory filing from Balyasny Asset Management reveals intense investor activity as a bidding war for narcolepsy drugmaker Avadel heats up.

A routine UK disclosure by an investment giant has pulled back the curtain on a major transatlantic auto merger and the silent influence of institutional capital.